Skip to main content
. 2019 May 14;9(5):e026779. doi: 10.1136/bmjopen-2018-026779

Figure 2.

Figure 2

DCBI production process: Monocytes are isolated from peripheral blood and are then stimulated to differentiate towards immature dendritic cells. These immature dendritic cells are exposed to PheraLys tumour cell lysate. After further differentiation towards mature dendritic cells, MesoPher vaccinations are given back to the patient. DCBI, dendritic cell based immunotherapy.